151 related articles for article (PubMed ID: 23812803)
1. The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis.
Marques FA; Lins TC; Lima RM; Fonseca RM; de França NM; de Oliveira RJ; de Oliveira Cardoso MT; Pereira RW; Pogue R
Endocrine; 2014 Apr; 45(3):487-96. PubMed ID: 23812803
[TBL] [Abstract][Full Text] [Related]
2. A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest.
Hartin SN; Hossain WA; Manzardo AM; Brown S; Fite PJ; Bortolato M; Butler MG
Growth Horm IGF Res; 2018 Aug; 41():48-53. PubMed ID: 29459141
[TBL] [Abstract][Full Text] [Related]
3. Association of the growth hormone receptor gene polymorphisms with mandibular height in a Korean population.
Kang EH; Yamaguchi T; Tajima A; Nakajima T; Tomoyasu Y; Watanabe M; Yamaguchi M; Park SB; Maki K; Inoue I
Arch Oral Biol; 2009 Jun; 54(6):556-62. PubMed ID: 19344888
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein receptor-related protein 5 gene polymorphisms and osteoporosis in Thai menopausal women.
Kitjaroentham A; Hananantachai H; Phonrat B; Preutthipan S; Tungtrongchitr R
J Negat Results Biomed; 2016 Sep; 15(1):16. PubMed ID: 27582019
[TBL] [Abstract][Full Text] [Related]
5. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
[TBL] [Abstract][Full Text] [Related]
6. Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.
Pontes J; Madeira M; Lima CHA; Ogino LL; de Paula Paranhos Neto F; de Mendonça LMC; Farias MLF; Kasuki L; Gadelha MR
J Endocrinol Invest; 2020 Feb; 43(2):163-171. PubMed ID: 31392573
[TBL] [Abstract][Full Text] [Related]
7. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP.
Glad CA; Johannsson G; Carlsson LM; Svensson PA
Growth Horm IGF Res; 2010 Jun; 20(3):270-3. PubMed ID: 20219401
[TBL] [Abstract][Full Text] [Related]
8. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
[TBL] [Abstract][Full Text] [Related]
9. The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population.
Glad CA; Carlsson LM; Melander O; Almgren P; Sjöström L; Nilsson S; Larsson I; Svensson PA; Johannsson G
Eur J Endocrinol; 2015 Feb; 172(2):123-8. PubMed ID: 25391539
[TBL] [Abstract][Full Text] [Related]
10. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
Adetunji OR; MacFarlane IA; Javadpour M; Alfirevic A; Pirmohamed M; Blair JC
Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
[TBL] [Abstract][Full Text] [Related]
11. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
[TBL] [Abstract][Full Text] [Related]
12. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone receptor (GHR) gene polymorphism and scoliosis in Prader-Willi syndrome.
Butler MG; Hossain W; Hassan M; Manzardo AM
Growth Horm IGF Res; 2018 Apr; 39():29-33. PubMed ID: 29273483
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA).
Wan J; Atzmon G; Hwang D; Barzlai N; Kratzsch J; Cohen P
J Clin Endocrinol Metab; 2013 Jan; 98(1):E77-81. PubMed ID: 23162096
[TBL] [Abstract][Full Text] [Related]
15. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in young women of the city of São Paulo, Brazil: correlation with both collagen type I alpha 1 gene polymorphism and clinical aspects.
Barros ER; Kasamatsu TS; Ramalho AC; Hauache OM; Vieira JG; Lazaretti-Castro M
Braz J Med Biol Res; 2002 Aug; 35(8):885-93. PubMed ID: 12185380
[TBL] [Abstract][Full Text] [Related]
17. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
[TBL] [Abstract][Full Text] [Related]
18. Association of the C-509-->T polymorphism, alone of in combination with the T869-->C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women.
Yamada Y; Miyauchi A; Takagi Y; Tanaka M; Mizuno M; Harada A
J Mol Med (Berl); 2001 Apr; 79(2-3):149-56. PubMed ID: 11357939
[TBL] [Abstract][Full Text] [Related]
19. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density.
Eckstein M; Vered I; Ish-Shalom S; Shlomo AB; Shtriker A; Koren-Morag N; Friedman E
Isr Med Assoc J; 2002 May; 4(5):340-4. PubMed ID: 12040821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
